Drug
Xl888
Xl888: highest development phase Phase 1, developed by Exelixis. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Exelixis
Trials
| Drug | Phase | Indication |
|---|---|---|
| XL888 NCT03095781 | Phase 1 | Colorectal Adenocarcinoma |
Latest
No recent events.
Follow Xl888 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.